Early or childhood onset of Thymidine Kinase 2 Deficiency, a mitochondrial disease, demonstrated 30‐fold higher GDF15 levels compared to controls, with improvement in clinical outcomes and decreases in GDF15 after treatment with oral deoxynucleosides [50]. Here, TK2 is linked to inborn mitochondrial metabolism disorder.